The two health systems signed the agreement July 26 and are working together to use their volumes of deidentified data collected over the years to find diseases earlier and determine ideal treatment paths.
The algorithms and machine learning models that come from the agreement will help indicate proven treatment paths based on years of patient outcomes, according to the Aug. 16 AHA report.
According to the AHA, the evidence could eventually be made available to other health systems, helping them deliver more proactive and predictive care.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
